DHA and EPA in Health and Disease
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 63
Special Issue Editors
Interests: astrocytes; omega-3 PUFA; neuroinflammation; neurodegeneration
Interests: astrocytes; neurons; microglia; neuroinflammation; polyunsaturated fatty acids; neuroprotection
Special Issue Information
Dear Colleagues,
Docosahexaenoic and Eicosapentaenoic Acids (DHA and EPA) are omega-3 polyunsaturated fatty acids that are the subject of intense scientific research due to their profound implications for human health and disease. Considering their role in maintaining the structural integrity and functionality of cell membranes and, therefore, cell function, DHA and EPA have gained attention as potential therapeutic agents for a variety of diseases. In the field of neurobiology, omega-3 PUFAs undoubtedly have an important role in neural development, synaptic plasticity and neuroinflammation, making it a compelling focus for researchers investigating neurodegenerative diseases and cognitive decline. Additionally, the anti-inflammatory and cardioprotective properties of these fatty acids direct research toward the determination of their role in cardiovascular health. Finally, in the context of growing concern about respiratory health in particular, the significance of DHA and EPA in regulating inflammation and oxidative stress—critical factors in the development of respiratory diseases—should not be overlooked.
Subsequently, both DHA and EPA can be easily supplemented from exogenous sources (such as sea fish, nuts or seeds); therefore, learning about their beneficial properties seems vital for modern therapy development.
This Special Issue of Pharmaceuticals (IF 4.6), entitled "DHA and EPA in Health and Disease", welcomes the submissions of manuscripts which either include original research or reviews of the scientific literature.
Our aim is to collect research from experts in the field summarizing the available knowledge about DHA and EPA in broadly understood pathological processes as well as in healthy states.
We believe this type of almanac would be a good starting point for new considerations and innovative future research.
Dr. Anna Walczewska
Dr. Emilia Zgórzyńska
Dr. Katarzyna Wieczorek-Szukała
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- omega-3 polyunsaturated fatty acids
- DHA
- EPA
- inflammation
- oxidative stress
- dietary supplements
- cognitive decline
- mental health
- therapeutic strategies
- cardiovascular diseases
- hypertension
- respiratory diseases
